Washington University School of Medicine
St Louis, Missouri, 63110, United States
NCT Number: NCT00682110
The purpose of the study is to determine if the less invasive monitors are as reliable for measuring heart function in patients undergoing liver transplantation as the more invasive pulmonary artery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
St Louis, Missouri, 63110, United States
Pulmonary artery catheter (PAC)is considered the gold standard in monitoring of heart function during orthotopic liver transplantation (OLT). Placement of PAC is very invasive (it passes thorough the heart chambers and into the pulmonary artery) and its benefits on the outcomes have not been proven. This study compares two newer FDA approved much less invasive devices to the PAC. The two new devices assess the heart function based either on the peripheral arterial waveform alone (Vigileo, Edwards Lifesciences)or the combination of peripheral arterial waveform and chemical indicator dilution (LiDCO, Cambridge, UK).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Specific phases of liver transplantation surgery
Washington University School of Medicine
Other
Comparing Different Methods For Measurement of Cardiac Output During Orthotopic Liver Transplantation
Acronym: OLT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04572373
Digestive System Diseases, End Stage Liver Disease
Kaohsiung City, Niaosong District, Taiwan
View Trial DetailsNCT05647733
Digestive System Diseases, End Stage Liver Disease
Vancouver, British Columbia, Canada
View Trial DetailsNCT07519057
Digestive System Diseases, End Stage Liver Disease
Warsaw, Poland
View Trial DetailsNCT07585890
Acute Liver Failure, Digestive System Diseases
Torino, Italy
View Trial Details